Regulatory News
Subscribe to Regulatory News

The Lead

J&J Settles $7.8 Million Lawsuit

May 19, 2015 10:35 am | by AP | News | Comments

Three years ago a jury found that a subsidiary, Janssen Pharmaceutical, committed Medicaid fraud and violated a state law in its labeling and marketing of Risperdal. A $1.2 billion fine was initially imposed on Johnson & Johnson.

Governor Says Nebraska Has Ordered New Death Penalty Drugs

May 15, 2015 11:39 am | by Grant Schulte, The Associated Press | News | Comments

Steps are being taken to resume executions in a state that hasn't imposed the death penalty...

Colombian Ban on Anti-Coca Herbicide is Bittersweet

May 14, 2015 11:54 am | by Jacobo Garcia, Associated Press | News | Comments

Colombian President Santos last week decided to halt fumigation in the wake of a report by a...

Personalized Medicine Gaining Traction, Facing Challenges

May 14, 2015 11:48 am | by Tufts Center for the Study of Drug Development | News | Comments

Thirteen percent of drugs marketed in the United States today post pharmacogenomic information...

View Sample

FREE Email Newsletter

ProPharma Group Acquires PROSAR

May 14, 2015 11:21 am | by ProPharma Group | News | Comments

ProPharma Group, a  compliance services company, today announced its acquisition of PROSAR, a provider of pharmacovigilance and medical information services.

Pennsylvania Senate Passes Medical Marijuana Bill

May 13, 2015 11:36 am | by Marc Levy, Associated Press | News | Comments

State senators, for a second time, have sent legislation legalizing medical marijuana to the House of Representatives, where the GOP majority has held hearings but given no certain signs of support.

Obamacare Ruling Could Impact States, But Not Lawmakers

May 13, 2015 11:26 am | by Ricardo Alonso-Zaldivar, Associated Press | News | Comments

If the Supreme Court rules the way most Republicans want in the latest health overhaul case, GOP lawmakers who now have insurance coverage under President Barack Obama's law may wind up with some explaining to do.


FDA Panel Backs Vertex Combination Pill for Cystic Fibrosis

May 13, 2015 11:23 am | by Matthew Perrone, AP Health Writer | News | Comments

Federal health advisers recommended approval for an experimental combination drug to treat cystic fibrosis, despite unresolved questions about the benefit of one of the pill's two ingredients.

Tainted Synthetic Marijuana Sickens Users in Connecticut

May 5, 2015 11:20 am | by The Associated Press | News | Comments

Connecticut police say they are investigating a batch of tainted synthetic marijuana that has sent about a dozen people to the hospital.

Capital Investments: Regulations, Technology and ROI

May 5, 2015 10:45 am | by Jeff Reinke, Editorial director | Blogs | Comments

Pharmaceutical processors face a number of challenges in determining the direction they should take when considering internal investments – but a lack of options have never been amongst them.

Rural Hospitals Struggle to Stay Open, Adapt to Changes

May 4, 2015 11:27 am | by David A. Lieb, Associated Press | News | Comments

Sac-Osage is one of a growing number of rural U.S. hospitals closing their doors, citing a complex combination of factors that have put more financial pressure on facilities.

Medicare Contrast in Generic, Brand Prescribing

May 4, 2015 11:21 am | by Lauran Neergaard, AP Medical Writer | News | Comments

The most-used medicines in Medicare's prescription drug program are generics, but the program spends the most on brand-name drugs, led by the heartburn treatment Nexium.


PhRMA Critiques 21st Century Cures Bill

April 30, 2015 12:36 pm | by Pharmaceutical Research and Manufacturers of America (PhRMA) | News | Comments

The Pharmaceutical Research and Manufacturers of America (PhRMA) today released statements in that were critical of bills in the House and Senate aimed at curbing abusive patent litigation.

FDA Approves First Generic Abilify

April 29, 2015 11:22 am | by FDA | News | Comments

The U.S. Food and Drug Administration today approved the first generic versions of Abilify (aripiprazole).

Rash of K2 Overdoses in Nebraska Prompts Legislative Study

April 28, 2015 5:00 pm | by The Associated Press | News | Comments

K2 is a synthetic plant product sprayed with dangerous chemicals to mimic the high of natural marijuana.

U.S. Supreme Court to Consider Challenge to Execution Drug

April 28, 2015 4:56 pm | by TIM TALLEY, Associated Press | News | Comments

The ruling could force several states to either find new execution drugs or change the way they put prisoners to death.

FDA Enters Consent Decree With Medtronic

April 28, 2015 11:22 am | by US Food and Drug Administration | News | Comments

The consent decree cites violations of the quality system regulation for medical devices, which requires manufacturers to have processes in place to assure that the design, manufacture and distribution of a device allows for its safe use.


Students' Device Detects Marijuana Use by Motorists

April 27, 2015 10:59 am | by The Associated Press | News | Comments

Two biomedical engineering graduate students at the University of Akron hope to market their roadside testing device to states where marijuana use has been legalized.

Hawaii Poised to Become 1st State to Raise Smoking Age to 21

April 27, 2015 10:55 am | by CATHY BUSSEWITZ, Associated Press | News | Comments

The bill would prevent adolescents from smoking, buying or possessing both traditional and electronic cigarettes.

Washington Gov. Signs Overhaul of Medical Marijuana Market

April 27, 2015 10:51 am | by RACHEL LA CORTE and GENE JOHNSON, Associated Press | News | Comments

Nearly two decades after voters passed a medical marijuana law that often left police, prosecutors and even patients confused about what was allowed. Gov. Jay Inslee signed a bill Friday attempting to clean up that largely unregulated system and harmonize it with Washington's new market for recreational pot.

With Bird Flu Spreading, USDA Starts on Potential Vaccine

April 22, 2015 5:00 pm | by STEVE KARNOWSKI, Associated Press | News | Comments

The U.S. Department of Agriculture is working on a vaccine to counter a deadly strain of bird flu, as losses to poultry producers mount.

Medical, Recreational Marijuana Stores Revenue to Grow 30.3 Percent Annually

April 21, 2015 10:58 am | by IBISWorld Media | News | Comments

The medical and recreational marijuana stores industry has reached new highs, riding a wave of legalization to become one of the fastest growing industries in the United States.

Glaxo Recalls Flu Vaccine Due to Potency Problem

April 17, 2015 3:37 pm | by MATTHEW PERRONE, AP Health Writer | News | Comments

The company alerted U.S. customers Tuesday that the vaccine can lose potency and fail to adequately protect against some strains of the flu.

USDA Veterinarian: Bird Flu Outbreak Could be 'Devastating'

April 17, 2015 3:02 pm | by STEVE KARNOWSKI, Associated Press | News | Comments

The nation's poultry industry may have to live with a deadly bird flu strain for several years, which would be "devastating," the U.S. Department of Agriculture's chief veterinary officer said Thursday.

U.S. Marshals Seize Unapproved Drugs From Florida Distributor

April 16, 2015 3:31 pm | by | News | Comments

Stratus Pharmaceuticals marketed and distributed unapproved prescription drug products that were manufactured by Sonar Products, Inc., of Carlstadt, New Jersey.

California Vaccine Bill Stalls; Will Cycle Back Next Week

April 16, 2015 10:47 am | by Judy Lin, Associated Press | News | Comments

A California vaccination bill that has generated intense debates and pitted personal rights against public health, stalled in the state Senate.

Ending Religious Waivers For Vaccines Back For Heated Debate

April 15, 2015 2:55 pm | by The Associated Press | News | Comments

California lawmakers are preparing for another round of heated talks Wednesday on whether the state should prevent parents from seeking vaccination exemptions for their children because of religious or personal beliefs.

FDA Warns of Liver Injury From Muscle-Building Supplement

April 14, 2015 2:05 pm | by MATTHEW PERRONE, AP Health Writer | News | Comments

The Food and Drug Administration is warning consumers to avoid dietary supplements sold by a Las Vegas company because they may contain anabolic steroids that can cause liver damage.

Actavis: No Apologies for Seeking Alzheimer's Drug Profits

April 14, 2015 10:45 am | by Larry Neumeister, Associated Press | News | Comments

A lawyer for Actavis urged a U.S. appeals court on Monday to let it replace a two-pill daily regimen with a single-dose version of the drug even if it cheats generic drugmakers of profits.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.